TScan Therapeutics retention program grants cash and RSUs to CEO, CFO, CMO tied to TSC-101 milestone

TScan Therapeutics, Inc.

Board approved retention program for CEO Gavin MacBeath, CFO Jason Amello, and CMO Chrystal Louis.
Cash awards: $399K (CEO), $170K (CFO), $250K (CMO); 50% paid upon TSC-101 pivotal trial milestone, 50% on first anniversary.
Equity awards: 1M RSUs (CEO), 270K RSUs (CFO), 650K RSUs (CMO) granted upon milestone; vest 25% at year 2, 75% at trial completion or year 4.
Awards subject to continued employment and terms of 2021 Equity Incentive Plan.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.